Immunocore Holdings plc
IMCR
$33.29
$1.424.44%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -10.30M | 5.02M | -23.77M | 8.74M | -11.62M |
| Total Depreciation and Amortization | 780.00K | 854.00K | 1.17M | 1.04M | 992.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.75M | 2.17M | 16.90M | -6.66M | 6.87M |
| Change in Net Operating Assets | 26.74M | -7.61M | -8.25M | 18.01M | 27.22M |
| Cash from Operations | 25.96M | 435.00K | -13.95M | 21.13M | 23.47M |
| Capital Expenditure | -414.00K | -298.00K | -3.58M | -828.00K | -331.00K |
| Sale of Property, Plant, and Equipment | -- | -- | 44.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -30.00M | 10.00M | 0.00 | 0.00 | -350.00M |
| Cash from Investing | -30.41M | 9.70M | -3.54M | -828.00K | -350.33M |
| Total Debt Issued | -- | -- | 0.00 | 0.00 | 0.00 |
| Total Debt Repaid | -- | -- | -52.06M | -- | -- |
| Issuance of Common Stock | 3.67M | 2.55M | 550.00K | 198.00K | 298.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | 0.00 | -1.12M |
| Cash from Financing | 3.67M | 2.55M | -51.51M | 198.00K | -818.00K |
| Foreign Exchange rate Adjustments | 11.87M | 8.43M | -13.03M | 12.29M | -159.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 11.09M | 21.11M | -82.04M | 32.78M | -327.84M |